These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7240998)

  • 1. Cell-mediated immunity in childhood malignancies.
    Suvatte V; Tuchinda M
    J Med Assoc Thai; 1981 Mar; 64(3):101-8. PubMed ID: 7240998
    [No Abstract]   [Full Text] [Related]  

  • 2. [The function of the immune system after the treatment of pediatric malignant diseases].
    Gadó J; Schlick B; Bárány O; Németh J; Müller J; Csóka M; Constantin T; Vonnák E; Böcskei R; Hauser P; Kovács G
    Orv Hetil; 2006 Sep; 147(36):1731-8. PubMed ID: 17087017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Specific cellular immunity indices in acute leukemia in children].
    Osipov SG; Bergol'ts VM; Eremeev VS; Akimova GV; Rumiantsev AG
    Vopr Onkol; 1981; 27(1):20-2. PubMed ID: 7456440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-SV-40 complement-fixing antibodies in tumors of childhood].
    Benso L; Brunet MR; Iudicello P
    Minerva Pediatr; 1970 Mar; 22(9):428-32. PubMed ID: 4315072
    [No Abstract]   [Full Text] [Related]  

  • 5. [Malignant tumors and immunity].
    Schuler D
    Orv Hetil; 1971 Oct; 112(42):2511-6. PubMed ID: 4943844
    [No Abstract]   [Full Text] [Related]  

  • 6. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
    Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acrodermatitis enteropathica: zinc levels and cell-mediated immunity.
    Chandra RK
    Pediatrics; 1980 Nov; 66(5):789-91. PubMed ID: 7432887
    [No Abstract]   [Full Text] [Related]  

  • 8. The human major histocompatibility complex and childhood leukemia: an etiological hypothesis based on molecular mimicry.
    Taylor M; Hussain A; Urayama K; Chokkalingam A; Thompson P; Trachtenberg E; Buffler P
    Blood Cells Mol Dis; 2009; 42(2):129-35. PubMed ID: 19054700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation.
    Wu F; Wang ZB; Lu P; Xu ZL; Chen WZ; Zhu H; Jin CB
    Ultrasound Med Biol; 2004 Sep; 30(9):1217-22. PubMed ID: 15550325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of childhood leukemia associated with vaccination, infection, and medication use in childhood: the Cross-Canada Childhood Leukemia Study.
    MacArthur AC; McBride ML; Spinelli JJ; Tamaro S; Gallagher RP; Theriault GP
    Am J Epidemiol; 2008 Mar; 167(5):598-606. PubMed ID: 18079130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergies and childhood leukemia.
    Chang JS; Wiemels JL; Buffler PA
    Blood Cells Mol Dis; 2009; 42(2):99-104. PubMed ID: 19049852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Letter: Cellular immunity and hairy cell leukemia].
    Lang J; Oberling F; Mors R; Mayer S
    Nouv Presse Med; 1974 Nov 30-Dec 14; 3(41-43):2578. PubMed ID: 4467128
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical and laboratory studies on childhood acute leukemia with 11q23 abnormalities].
    He YX; Xue YQ; He J; Zhang XL; Ji ZH; Huang YP; Zhu XM; He HL; Chai YH; Zhu LL
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):358-61. PubMed ID: 12941190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parental age as a risk factor of childhood leukemia and brain cancer in offspring.
    Hemminki K; Kyyrönen P; Vaittinen P
    Epidemiology; 1999 May; 10(3):271-5. PubMed ID: 10230837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
    Pulte D; Gondos A; Brenner H
    J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in childhood cancer mortality as indicators of the quality of medical care in the developed world.
    La Vecchia C; Levi F; Lucchini F; Lagiou P; Trichopoulos D; Negri E
    Cancer; 1998 Nov; 83(10):2223-7. PubMed ID: 9827729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cellular immunotherapy of hematologic malignancies attempted using minor histocompatibility antigens as targets].
    Takami A; Shiobara S
    Rinsho Ketsueki; 2002 May; 43(5):360-2. PubMed ID: 12096487
    [No Abstract]   [Full Text] [Related]  

  • 19. Haemophilus influenzae type b serology in childhood leukaemia: a case-control study.
    Groves FD; Sinha D; Kayhty H; Goedert JJ; Levine PH
    Br J Cancer; 2001 Aug; 85(3):337-40. PubMed ID: 11487261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunosuppression during the treatment of solid tumours and acute leukaemia in childhood].
    Neidhardt M
    Ger Med Mon; 1969 Feb; 14(2):86-9. PubMed ID: 4894172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.